Compound: 129-56-6
SMILES: O=C1c2c(-c3n[nH]c4c3c1ccc4)cccc2
InChIKey: ACPOUJIDANTYHO-UHFFFAOYSA-N
Synonyms: 129-56-6, 1,9-Pyrazoloanthrone, SP600125, Pyrazolanthrone, Pyrazoleanthrone, Anthra[1,9-cd]pyrazol-6(2H)-one, ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE, 2H-Dibenzo[cd,g]indazol-6-one, C.I. 70300, 2h-dibenzo(cd,g)indazol-6-one, NSC75890, DTXSID2040525, 1TW30Y2766, DTXCID0020525, CHEBI:90695, RefChem:113038, 14,15-diazatetracyclo(7.6.1.0^(2,7).0^(13,16))hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one, 204-955-6, Dibenzo[cd,g]indazol-6(2H)-one, SP 600125, SP-600125, JNK Inhibitor II, MFCD00022289, NSC 75890, NSC-75890, 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one, CHEMBL7064, MLS002693964, Anthra-1,9-pyrazol-6-none, dibenz[cd,g]indazol-6(2h)-one, NCGC00015958-03, SMR000015440, SR-01000075840, EINECS 204-955-6, BRN 0746890, Pyrazolanthrone;, Anthrapyrazolone;, UNII-1TW30Y2766, 1pmv, 2zmd, Kinome_3844, Tocris-1496, CI 70300, BiomolKI_000068, Lopac-S-5567, BiomolKI2_000072, cid_8515, CBiol_002049, Lopac0_000473, BMK1-G8, BSPBio_001066, ChemBiol10705 Compound 4, KBioGR_000406, KBioSS_000406, JMC517015 Compound 2, MLS002153267, MLS006011577, SCHEMBL170980, anthra[1,9-cd]pyrazol-6-one, GTPL5273, orb1304531, Pyrazolanthrone (SP600125), CHEMBL1725279, SCHEMBL15583517, SCHEMBL29353146, SCHEMBL29693577, SCHEMBL29941507, BCBcMAP01_000053, BDBM16018, KBio2_000406, KBio2_002974, KBio2_005542, KBio3_000771, KBio3_000772, Bio1_000335, Bio1_000824, Bio1_001313, Bio2_000373, Bio2_000853, GLXC-03091, HMS1362F07, HMS1667K13, HMS1792F07, HMS1990F07, HMS2250C03, HMS3229I16, HMS3261O08, HMS3267P06, HMS3295M01, HMS3403F07, HMS3412F05, HMS3654P10, HMS3676F05, HMS3747M19, PS653, ALBB-024051, Anthra[1,9cd]pyrazol-6(2H)-one, EX-A1998, Tox21_110267, Tox21_500473, BDBM50024294, BDBM50433916, CCG-47500, Dibenzo[cd,g]indazol-6(2H)-one #, EBC-11070, HB2234, HSCI1_000136, NSC755773, PS-653, s1460, SBB000595, AKOS000115584, AKOS040751313, Anthra[1,9-cd]pyrazol-6(2H)-one;, Anthrapyrazolone; 1,9-Pyrazoloanthrone, CCG-100672, CS-0196, DB01782, FP33726, LP00473, NSC-755773, SDCCGSBI-0050458.P003, SDCCGSBI-0050458.P009, WLN: T C66651A P IV OMNJ, 1,6-dihydrodibenzo[cd,g]indazol-6-one, 2,6-dihydrodibenzo[cd,g]indazol-6-one, IDI1_002128, QTL1_000077, s10332, SMP2_000240, NCGC00015958-01, NCGC00015958-02, NCGC00015958-04, NCGC00015958-05, NCGC00015958-06, NCGC00015958-07, NCGC00015958-08, NCGC00015958-22, NCGC00025186-01, NCGC00025186-02, NCGC00025186-03, NCGC00025186-04, NCGC00025186-05, NCGC00261158-01, WLN: T C6665 1A P IV OMNJ, AC-32051, AS-14374, CAS-129-56-6, HY-12041, JNK Inhibitor II - CAS 129-56-6, SMR002530644, ST018684, SY052909, DB-041928, SP600125?, A2548, EU-0100473, NS00020981, SW218106-2, EN300-02083, Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100, K00068, S 5567, SP600125, >=98% (HPLC), AB00075935-01, SP 600125 & Z-100, AE-641/00620033, Q4545713, SR-01000075840-1, SR-01000075840-2, SR-01000075840-4, SR-01000075840-6, SR-01000637108-1, BRD-K01567962-001-04-0, BRD-K01567962-001-06-5, BRD-K01567962-001-08-1, BRD-K01567962-001-22-2, BRD-K01567962-001-23-0, BRD-K01567962-001-24-8, Z56785477, F1414-1245, dibenzo[cd,g]indazol-6(2H)-one; Anthra[1,9-cd]pyrazol-6(2H)-one, 14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one, 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
Theoretical properties:
molecular_formula: C14H8N2O
molecular_weight: 220.23 g/mol
exact_mass: 220.063662883 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 0
heavy_atom_count: 17
topological_polar_surface_area: 45.8 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Anthra[1,9-cd]pyrazol-6(2H)-one is a member of the class of anthrapyrazoles that is anthra[1,9-cd]pyrazole substituted at position 6 by an oxo group. An inhibitor of c-Jun N-terminal kinase. It has a role as a geroprotector, an antineoplastic agent and a c-Jun N-terminal kinase inhibitor. It is a cyclic ketone, an aromatic ketone and an anthrapyrazole.
chebi: A member of the class of anthrapyrazoles that is anthra[1,9-<em>cd</em>]pyrazole substituted at position 6 by an oxo group. An inhibitor of c-Jun <em>N</em>-terminal kinase.
chembl: Unnamed Compound is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: The 6.5mm Grendel (6.5×39mm) is an intermediate cartridge jointly designed by British-American armorer Bill Alexander, competitive shooter Arne Brennan (of Houston, Texas) and Lapua ballistician Janne Pohjoispää, as a low-recoil, high-precision rifle cartridge specifically for the AR-15 platform at medium/long range (200–800 yard).  It is an improved variation of the 6.5mm PPC.
The 6.5mm Grendel cartridge was first unveiled in May 2003 at the Blackwater Training Facility in North Carolina, where it remained supersonic at 1,200 yd (1,100 m) range and out-shot the 7.62mm NATO with only half the recoil. Since its introduction, it has proven to be a versatile cartridge and is now expanding into other firearm design platforms including bolt-action rifles and the Kalashnikov system.
The name "Grendel" is inspired by the mythical monster antagonist from the Old English epic poem Beowulf.  It was a trademark owned by Alexander Arms (Bill Alexander's company in Radford, Virginia) and manufactured at Radford Arsenal, until legally released in 2010 for SAAMI standardization with collaboration from Hornady.